Sigilon Therapeutics Inc (SGTX)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
22.47 -0.59 (-2.56%) 08/10/23 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 22.47 unch (unch) -
for Thu, Aug 10th, 2023
Results
download Want to compare other data? Select FieldsSymbol | SGTX | VANI | KPTI | ||
Company | Sigilon Therapeutics Inc | Vivani Medical Inc | Karyopharm Therapeut | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 22.90 | 1.0200 | 6.32 | ||
High | 23.10 | 1.0400 | 6.79 | ||
Low | 22.09 | 1.0200 | 6.25 | ||
Last | 22.47 | 1.0300 | 6.75 | ||
Change | -0.59 | unch | +0.40 | ||
% Change | -2.56% | unch | +6.30% | ||
Volume | 83,600 | 21,500 | 81,500 | ||
20-Day Average Volume | 39,030 | 82,515 | 118,045 | ||
Previous Close | 23.06 | 1.0300 | 6.35 | ||
Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
Has Options | No | Yes | Yes | ||
Technicals | |||||
20-Day Moving Average | 21.62 | 1.0260 | 4.93 | ||
20-Day Raw Stochastic | 58.58% | 71.36% | 98.78% | ||
20-Day Relative Strength | 71.60% | 45.29% | 57.07% | ||
Weighted Alpha | -18.40 | -38.05 | -49.71 | ||
Today's Opinion | 100% Buy | 88% Sell | 56% Sell | ||
Previous Opinion | 100% Buy | 88% Sell | 56% Sell | ||
Last Month's Opinion | 72% Buy | 100% Sell | 100% Sell | ||
Performance | |||||
5-Days | |||||
%Chg | +4.27% since 08/03/23 | unch since 04/23/25 | +7.66% since 04/23/25 | ||
Low | 21.25 on 08/04/23 | 1.0100 on 04/25/25 | 5.52 on 04/28/25 | ||
High | 23.78 on 08/07/23 | 1.0674 on 04/29/25 | 6.79 on 04/30/25 | ||
1-Month | |||||
%Chg | +2.74% since 07/10/23 | -7.21% since 03/28/25 | +62.26% since 03/28/25 | ||
Low | 20.61 on 07/28/23 | 0.9054 on 04/04/25 | 3.51 on 04/01/25 | ||
High | 23.78 on 08/07/23 | 1.0800 on 04/17/25 | 6.79 on 04/30/25 | ||
3-Month | |||||
%Chg | +251.24% since 05/10/23 | -11.97% since 01/30/25 | -32.24% since 01/30/25 | ||
Low | 3.80 on 06/27/23 | 0.9054 on 04/04/25 | 3.51 on 04/01/25 | ||
High | 28.00 on 06/29/23 | 1.2000 on 01/31/25 | 10.38 on 02/27/25 | ||
6-Month | |||||
%Chg | +161.89% since 02/10/23 | -23.13% since 10/30/24 | -46.44% since 10/30/24 | ||
Low | 3.80 on 06/27/23 | 0.9054 on 04/04/25 | 3.51 on 04/01/25 | ||
High | 28.00 on 06/29/23 | 1.5000 on 11/27/24 | 16.95 on 10/31/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 56,501 | 61,012 | 54,417 | ||
Shares Outstanding, K | 2,514 | 59,235 | 8,570 | ||
Annual Sales | 12,940,000 | 0 | 145,240,000 | ||
Annual Net Income | -43,560,000 | -23,490,000 | -76,420,000 | ||
Last Quarter Sales | 4,860,000 | 0 | 30,540,000 | ||
Last Quarter Net Income | -7,380,000 | -6,050,000 | -30,780,000 | ||
60-Month Beta | 4.12 | 2.76 | 0.58 | ||
Per-Share Information | |||||
Most Recent Earnings | -2.89 on 08/07/23 | -0.11 on 03/31/25 | -3.60 on 02/19/25 | ||
Latest Earnings Date | 08/03/23 | 05/12/25 | 05/14/25 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 0.00 | 0.00 |